<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36081240</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-8952</ISSN><JournalIssue CitedMedium="Internet"><Volume>142</Volume><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology</Title><ISOAbbreviation>Clin Neurophysiol</ISOAbbreviation></Journal><ArticleTitle>Quantitative muscle ultrasound assessment using automatic thresholding methods in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>236</StartPage><EndPage>243</EndPage><MedlinePgn>236-243</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clinph.2022.08.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1388-2457(22)00861-6</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To evaluate the usefulness of automatic thresholding methods for quantitative assessments of muscle echogenicity in amyotrophic lateral sclerosis (ALS) patients.</AbstractText><AbstractText Label="METHODS">Thirty-one ALS patients and 31 matched healthy controls underwent ultrasound examination of the biceps brachii, rectus femoris and tibialis anterior muscles. Muscle echogenicity was evaluated using grayscale analysis and the 16 automatic thresholding methods of ImageJ program. The diagnostic value and correlations between ultrasound parameters and muscle strength were investigated.</AbstractText><AbstractText Label="RESULTS">Mean grayscale values (GSV) and mean hyperechoic fractions of 8 out of the 16 automatic thresholding methods were significantly different between patients and controls in all 3 muscles (p&#xa0;&lt;&#xa0;0.05 for all). Four thresholding methods (Default, Li, Moments, Otsu) showed a significant correlation between hyperechoic fractions and muscle strength, and diagnostic accuracy comparable or superior to GSVs. Otsu method was the only technique that detected ultrasound changes in normal strength muscles of ALS patients.</AbstractText><AbstractText Label="CONCLUSIONS">Our findings support the utility of automatic thresholding methods in muscle echogenicity studies as a supplementary ultrasound image analysis in ALS.</AbstractText><AbstractText Label="SIGNIFICANCE">In an era of advances in developing neurophysiological diagnostic tools and biomarkers in ALS, muscle ultrasonography and echogenicity analysis using automatic thresholding methods could be effectively implemented in clinical research.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Spiliopoulos</LastName><ForeName>Kanellos C</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, University of Patras, Patras, Greece. Electronic address: kanspiliopoulos@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veltsista</LastName><ForeName>Dimitra</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, University of Patras, Patras, Greece. Electronic address: dveltsista@yahoo.gr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chroni</LastName><ForeName>Elisabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, University of Patras, Patras, Greece. Electronic address: echroni@upatras.gr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Clin Neurophysiol</MedlineTA><NlmUniqueID>100883319</NlmUniqueID><ISSNLinking>1388-2457</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053580" MajorTopicYN="N">Muscle Strength</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Automatic thresholding</Keyword><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">Muscle echogenicity</Keyword><Keyword MajorTopicYN="N">Muscle ultrasound</Keyword><Keyword MajorTopicYN="N">Quantitative assessments</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>9</Day><Hour>1</Hour><Minute>38</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36081240</ArticleId><ArticleId IdType="doi">10.1016/j.clinph.2022.08.008</ArticleId><ArticleId IdType="pii">S1388-2457(22)00861-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>